Stuttgart - Delayed Quote EUR

Viatris Inc. (US92556V1061.SG)

7.87

+0.11

+(1.39%)

At close: 9:45:27 PM GMT+2

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the pharmaceuticals industry, including Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.

StockStory 6 days ago

JAZZ

ANIP

VTRS
Theravance's Q1 Loss Wider Than Expected, Revenues Rise Y/Y

TBPH reports weaker-than-expected first-quarter 2025 results. Collaboration revenues from Viatris rise year over year.

Zacks 11 days ago

TBPH

VTRS
Viatris Inc (VTRS) Q1 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on ...

Despite a revenue dip and goodwill impairment, Viatris Inc (VTRS) focuses on strategic growth, shareholder returns, and promising new product developments.

GuruFocus.com 11 days ago

VTRS
Q1 2025 Viatris Inc Earnings Call

Q1 2025 Viatris Inc Earnings Call

Thomson Reuters StreetEvents 11 days ago

VTRS
Viatris Q1 Earnings and Revenues Beat Estimates, Stock Gains

VTRS Q1 earnings and sales beat estimates. Brands business continues to perform well backed by expansion of portfolio.

Zacks 12 days ago

VTRS
Viatris (NASDAQ:VTRS) Reports Sales Below Analyst Estimates In Q1 Earnings, But Stock Soars 8%

Medication company Viatris (NASDAQ:VTRS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 11.2% year on year to $3.25 billion. The company’s full-year revenue guidance of $13.75 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.50 per share was in line with analysts’ consensus estimates.

StockStory 12 days ago

VTRS
Viatris (VTRS) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Viatris (VTRS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks 12 days ago

VTRS
Viatris (VTRS) Beats Q1 Earnings and Revenue Estimates

Viatris (VTRS) delivered earnings and revenue surprises of 2.04% and 0.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 12 days ago

VTRS

AUNA
Viatris: Q1 Earnings Snapshot

CANONSBURG, Pa. AP) — Viatris Inc (VTRS) on Thursday reported a loss of $3.04 billion in its first quarter. On a per-share basis, the Canonsburg, Pennsylvania-based company said it had a loss of $2.55.

Associated Press Finance 12 days ago

VTRS
Viatris Earnings: What To Look For From VTRS

Medication company Viatris (NASDAQ:VTRS) will be reporting results tomorrow morning. Here’s what you need to know.

StockStory 13 days ago

VTRS
Sector Update: Health Care Stocks Fall Late Afternoon

Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index falling 2.6% and

PREMIUM
MT Newswires 14 days ago

VTRS
Unveiling Viatris (VTRS) Q1 Outlook: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Viatris (VTRS) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks 15 days ago

VTRS
2 S&P 500 Stocks Worth Investigating and 1 to Avoid

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

StockStory 15 days ago

^GSPC

VTRS

SYK
Viatris Q1 Earnings Release: What's in Store for the Stock?

VTRS' Q1 results are likely to gain from new product launches in all major geographies.

Zacks 18 days ago

VTRS
Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for

Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 19 days ago

VTRS

ESTA
Viatris Inc. (VTRS): Among the Worst Performing Stocks in S&P 500 So Far in 2025

We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other worst performing stocks this year. After a two-year surge of 53%, marking the best performance for the broad market index since […]

Insider Monkey 19 days ago

VTRS

^GSPC
Viatris Inc. (VTRS): One of the Cheap Quarterly Dividend Stocks to Buy Now

We recently published a list of the 10 Cheap Quarterly Dividend Stocks to Buy Now. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other overlooked dividend stocks. In the current market environment, investors are looking to seek stable income as a way to protect themselves against a […]

Insider Monkey 21 days ago

VTRS
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

Let’s dig into the relative performance of Viatris (NASDAQ:VTRS) and its peers as we unravel the now-completed Q4 generic pharmaceuticals earnings season.

StockStory 22 days ago

VTRS

ANIP
Viatris Inc. (VTRS): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this article, we are going to take a look at where Viatris Inc. (NASDAQ:VTRS) stands against other Billionaire Ken Fisher’s healthcare stock picks with massive upside potential. The healthcare industry, an essential component of global well-being and […]

Insider Monkey 23 days ago

VTRS
3 Reasons VTRS is Risky and 1 Stock to Buy Instead

Viatris’s stock price has taken a beating over the past six months, shedding 33% of its value and falling to $7.69 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.

StockStory 26 days ago

VTRS

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Viatris Inc. (US92556V1061.SG)

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Theravance's Q1 Loss Wider Than Expected, Revenues Rise Y/Y

Viatris Inc (VTRS) Q1 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing on ...

Q1 2025 Viatris Inc Earnings Call

Viatris Q1 Earnings and Revenues Beat Estimates, Stock Gains

Viatris (NASDAQ:VTRS) Reports Sales Below Analyst Estimates In Q1 Earnings, But Stock Soars 8%

Viatris (VTRS) Reports Q1 Earnings: What Key Metrics Have to Say

Viatris (VTRS) Beats Q1 Earnings and Revenue Estimates

Viatris: Q1 Earnings Snapshot

Viatris Earnings: What To Look For From VTRS

Sector Update: Health Care Stocks Fall Late Afternoon

Unveiling Viatris (VTRS) Q1 Outlook: Wall Street Estimates for Key Metrics

2 S&P 500 Stocks Worth Investigating and 1 to Avoid

Viatris Q1 Earnings Release: What's in Store for the Stock?

Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for

Viatris Inc. (VTRS): Among the Worst Performing Stocks in S&P 500 So Far in 2025

Viatris Inc. (VTRS): One of the Cheap Quarterly Dividend Stocks to Buy Now

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

Viatris Inc. (VTRS): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

3 Reasons VTRS is Risky and 1 Stock to Buy Instead